Correction to: Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. J Child Adolesc Psychopharmacol 2018;28(7):437-444. DOI: 10.1089/cap.2018.0030
- PMID: 30585735
- PMCID: PMC6354592
- DOI: 10.1089/cap.2018.0030.correx
Correction to: Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. J Child Adolesc Psychopharmacol 2018;28(7):437-444. DOI: 10.1089/cap.2018.0030
Erratum for
-
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study.J Child Adolesc Psychopharmacol. 2018 Sep;28(7):437-444. doi: 10.1089/cap.2018.0030. Epub 2018 Jul 13. J Child Adolesc Psychopharmacol. 2018. PMID: 30004254 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
